Bengaluru, India

Venkateshwar Rao Gunmadi

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkateshwar Rao Gunmadi. Retrieved from https://idiyas.com/inventor/venkateshwar-rao-gunmadi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venkateshwar Rao Gunmadi: Innovator in Pharmaceutical Compounds

Introduction

Venkateshwar Rao Gunmadi is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific enzymes.

Latest Patents

Gunmadi holds a patent for "Inhibitors of CYP 17." This invention provides compounds of Formula (I) and (II), or pharmaceutically acceptable salts thereof, where R, R, p, q, and n are defined within the patent. The compounds have been identified as useful as 17α-hydroxylase/C-lyase inhibitors, showcasing their potential in therapeutic applications.

Career Highlights

He is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in drug development and contribute to advancements in medical science.

Collaborations

Gunmadi has collaborated with esteemed colleagues, including Mark G Bock and Saumitra Sengupta. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.

Conclusion

Venkateshwar Rao Gunmadi's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to impact the development of important therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…